Versant Capital Management »

Capricor Therapeutics shares owned by Versant Capital Management

Quarter-by-quarter ownership of Capricor Therapeutics (CAPR) shares owned by Versant Capital Management from 13F filings

Historical chart of Versant Capital Management investment in Capricor Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Capricor Therapeutics held by Versant Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Capricor Therapeutics by Versant Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $4.7k 156 30.40

More positions owned by Versant Capital Management

Microsoft Stock (MSFT)
Avantis International Equity Etf Etf (AVDE)
Flexshares Tr Mornstar Upstr Etf (GUNR)
Dimensional U.s. Core Equity 2 Etf Etf (DFAC)
Avantis Emerging Markets Equity Etf Etf (AVEM)
Ishares S&p Global Energy Etf (IXC)
Vaneck Gold Miners Etf Etf (GDX)
Dimensional International Core Equity 2 Etf Etf (DFIC)
Apple Stock (AAPL)
Avago Technologies Stock (AVGO)
Nvidia Corp Stock (NVDA)
Ishares Gold Trust Micro Etf Of Benef Interest Etf (IAUM)
Vanguard Total Stk Mkt Etf (VTI)
State Street Spdr S&p Global Natural Resources Etf Etf (GNR)
Global X Fds Global X Ftse Greece 20 Etf Etf (GREK)

View all positions for Versant Capital Management

Top funds holding Capricor Therapeutics

BlackRock
Susquehanna International
Vanguard Group
Point72 Asset Management
Citadel Advisors
Suvretta Capital Management
Tang Capital Management
RA Capital Management
Geode Capital Management
FMR
J. Goldman & Co
Caption Management
State Street Corporation
Darwin Global Management
Millennium Management

View all funds holding Capricor Therapeutics